|
|
|
|
LEADER |
01823nam a22002775i 4500 |
001 |
978-3-319-41319-8 |
005 |
20191023111146.0 |
007 |
cr nn 008mamaa |
008 |
170125s2017 gw | s |||| 0|eng d |
020 |
|
|
|a 9783319413198
|
024 |
7 |
|
|a 10.1007/978-3-319-41319-8
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Melanoma Development
|b Molecular Biology, Genetics and Clinical Application /
|c edited by Anja K. Bosserhoff.
|
250 |
|
|
|a 2nd ed. 2017.
|
260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2017.
|
300 |
|
|
|a VIII, 447 p. 36 illus., 26 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Clinicopathologic Overview of Melanoma -- Revisiting Epidermal Melanocytes: Regulation of Their Survival, Proliferation, and Function in Human Skin -- Melanoma Epidemiology -- Melanoma Genetics and Genomics -- Transcriptional Regulation in Melanoma -- MiRNAs in Malignant Melanoma -- Altered Signal Transduction Pathways in Melanoma -- Proteases in Melanoma -- Cell-cell contacts in melanoma and the tumor microenvironment -- Regulation of Apoptosis in Melanoma Cells: Critical Targets for Therapeutic Strategies -- Senescence -- Melanoma Stem Cells -- The Birth of Malignancy: Embryogenesis and Melanoma -- Tumor Microenvironment for Melanoma Cells -- Melanoma Model Systems -- New Approaches to Signaling -- Immune checkpoint inhibitors in melanoma define a new area in immunotherapy aiming for cure. .
|
650 |
|
0 |
|a Cancer research.
|
650 |
1 |
4 |
|a Cancer Research.
|
700 |
1 |
|
|a Bosserhoff, Anja K.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-41319-8
|